BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22276948)

  • 1. Mechanism of cell cycle entry mediated by the intrinsically disordered protein p27(Kip1).
    Ou L; Waddell MB; Kriwacki RW
    ACS Chem Biol; 2012 Apr; 7(4):678-82. PubMed ID: 22276948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.
    Ray A; James MK; Larochelle S; Fisher RP; Blain SW
    Mol Cell Biol; 2009 Feb; 29(4):986-99. PubMed ID: 19075005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein.
    Ou L; Ferreira AM; Otieno S; Xiao L; Bashford D; Kriwacki RW
    J Biol Chem; 2011 Aug; 286(34):30142-51. PubMed ID: 21715330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
    Paternot S; Coulonval K; Dumont JE; Roger PP
    J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic protein flexibility in regulation of cell proliferation: advantages for signaling and opportunities for novel therapeutics.
    Follis AV; Galea CA; Kriwacki RW
    Adv Exp Med Biol; 2012; 725():27-49. PubMed ID: 22399317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity.
    James MK; Ray A; Leznova D; Blain SW
    Mol Cell Biol; 2008 Jan; 28(1):498-510. PubMed ID: 17908796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.
    Bagui TK; Mohapatra S; Haura E; Pledger WJ
    Mol Cell Biol; 2003 Oct; 23(20):7285-90. PubMed ID: 14517297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.
    Tsutsui T; Hesabi B; Moons DS; Pandolfi PP; Hansel KS; Koff A; Kiyokawa H
    Mol Cell Biol; 1999 Oct; 19(10):7011-9. PubMed ID: 10490638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits.
    Galea CA; Wang Y; Sivakolundu SG; Kriwacki RW
    Biochemistry; 2008 Jul; 47(29):7598-609. PubMed ID: 18627125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".
    Bockstaele L; Kooken H; Libert F; Paternot S; Dumont JE; de Launoit Y; Roger PP; Coulonval K
    Mol Cell Biol; 2006 Jul; 26(13):5070-85. PubMed ID: 16782892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
    Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.
    Zhang W; Bergamaschi D; Jin B; Lu X
    Blood; 2005 May; 105(9):3691-8. PubMed ID: 15665120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic anticipation by Cdk2/Cyclin A-bound p27 mediates signal integration in cell cycle regulation.
    Tsytlonok M; Sanabria H; Wang Y; Felekyan S; Hemmen K; Phillips AH; Yun MK; Waddell MB; Park CG; Vaithiyalingam S; Iconaru L; White SW; Tompa P; Seidel CAM; Kriwacki R
    Nat Commun; 2019 Apr; 10(1):1676. PubMed ID: 30976006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis.
    Coulonval K; Bockstaele L; Paternot S; Dumont JE; Roger PP
    Exp Cell Res; 2003 Nov; 291(1):135-49. PubMed ID: 14597415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.